PFE: Analysis & Opinions

  1. After A Big Rally, Pfizer Might Need Some Rest

    May 21, 2013
    A big rally has brought Pfizer back to fair value.
  2. Amgen Chased By The Bubble

    May 08, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  3. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is ...
  4. Agilent Misses, Guidance Disappoints - Analyst Blog

    February 15, 2013
    Agilent Technologies' A) fiscal first quarter earnings per share of 63 cents missed the Zacks Consensus Estimate by ...
  5. Agilent Unit & Pfizer Collaborate - Analyst Blog

    February 14, 2013
    Dako, an Agilent Technologies A) subsidiary, has entered into an agreement with Pfizer Inc. (PFE) related to the ...
  6. Data on Biogen Hemophilia Candidates - Analyst Blog

    February 11, 2013
    Biogen Idec (BIIB) and partner, Swedish Orphan Biovitrum recently presented encouraging data on their hemophilia ...
  7. Protalix Exploring Options - Analyst Blog

    February 07, 2013
    Protalix BioTherapeutics, Inc. (PLX) recently confirmed that it has hired Citigroup, Inc. C) to explore strategic ...
  8. Data on Auxilium's Xiaflex - Analyst Blog

    February 07, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that data from the pivotal phase III trials, IMPRESS (The ...
  9. Favorable Ruling for Pfizer - Analyst Blog

    February 07, 2013
    Pfizer Inc. (PFE) recently received a favorable ruling in its patent infringement case against Actavis, Inc. (ACT) ...
  10. Zoetis Commences Trading - Analyst Blog

    February 04, 2013
    Zoetis Inc. (ZTS), the former Animal Health business of Pfizer Inc. (PFE), started trading on the New York Stock ...
  11. Stock Market News for January 30, 2013 - Market News

    January 30, 2013
    Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. ...
  12. Positive Data on Spectrum Candidate - Analyst Blog

    January 29, 2013
    Spectrum Pharmaceuticals (SPPI) recently announced safety findings from the phase II BELIEF study on belinostat. ...
  13. MedTech Industry Stock Outlook - Jan 2013 - Zacks ...

    January 29, 2013
    We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
  14. MedTech Industry Stock Outlook - Jan 2013 - Industry Outlook

    January 29, 2013
    We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
  15. FDA to Review Sanofi's Lemtrada - Analyst Blog

    January 29, 2013
    Sanofi's (SNY) subsidiary, Genzyme, recently announced that the US Food and Drug Administration (FDA) has accepted ...
  16. Market News Fails to Disappoint - Analyst Blog

    January 29, 2013
    As the first FOMC meeting of 2013 gets underway today, it is perhaps appropriate to acknowledge the Fed's ...
  17. Pfizer Tops, Guides In Line - Analyst Blog

    January 29, 2013
    Pfizer Inc. (PFE) posted fourth quarter earnings of 47 cents per share, 3 cents above the Zacks Consensus Estimate ...
  18. Ahead of Wall Street - January 29, 2013 - Ahead of Wall ...

    January 29, 2013
    Tuesday, January 29, 2013 As the first FOMC meeting of 2013 gets underway today, it is perhaps appropriate to ...
  19. Generic Launch at Dr. Reddy's - Analyst Blog

    January 28, 2013
    Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) Singulair ...
  20. Earnings Preview: Pfizer - Analyst Blog

    January 28, 2013
    Pfizer (PFE) is slated to report its second quarter 2012 earnings on July 31, 2012 before the opening bell. The ...
Marketplace
Trading Center